annual net income:
-$130.87M-$60.08M(-84.86%)Summary
- As of today (June 17, 2025), EYPT annual net profit is -$130.87 million, with the most recent change of -$60.08 million (-84.86%) on December 31, 2024.
- During the last 3 years, EYPT annual net income has fallen by -$72.45 million (-124.03%).
- EYPT annual net income is now -1595.14% below its all-time high of $8.75 million, reached on June 30, 2010.
Performance
EYPT Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
-$45.20M-$3.80M(-9.17%)Summary
- As of today (June 17, 2025), EYPT quarterly net profit is -$45.20 million, with the most recent change of -$3.80 million (-9.17%) on March 31, 2025.
- Over the past year, EYPT quarterly net income has dropped by -$15.91 million (-54.33%).
- EYPT quarterly net income is now -220.32% below its all-time high of $37.56 million, reached on September 30, 2006.
Performance
EYPT quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$146.78M-$15.91M(-12.16%)Summary
- As of today (June 17, 2025), EYPT TTM net profit is -$146.78 million, with the most recent change of -$15.91 million (-12.16%) on March 31, 2025.
- Over the past year, EYPT TTM net income has dropped by -$67.87 million (-86.00%).
- EYPT TTM net income is now -763.26% below its all-time high of $22.13 million, reached on September 30, 2006.
Performance
EYPT TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
EYPT Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.9% | -54.3% | -86.0% |
| 3 y3 years | -124.0% | -115.5% | -118.7% |
| 5 y5 years | -130.4% | -243.1% | -189.3% |
EYPT Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -124.0% | at low | -258.4% | at low | -118.7% | at low |
| 5 y | 5-year | -188.3% | at low | -1089.0% | at low | -263.9% | at low |
| alltime | all time | -1595.1% | at low | -220.3% | +28.9% | -763.3% | at low |
EYPT Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$45.20M(+9.2%) | -$146.78M(+12.2%) |
| Dec 2024 | -$130.87M(+84.9%) | -$41.40M(+41.0%) | -$130.87M(+26.4%) |
| Sep 2024 | - | -$29.36M(-4.8%) | -$103.57M(+19.3%) |
| Jun 2024 | - | -$30.83M(+5.3%) | -$86.82M(+10.0%) |
| Mar 2024 | - | -$29.28M(+107.7%) | -$78.92M(+11.5%) |
| Dec 2023 | -$70.80M(-30.8%) | -$14.10M(+11.8%) | -$70.80M(-29.3%) |
| Sep 2023 | - | -$12.61M(-45.0%) | -$100.15M(-5.5%) |
| Jun 2023 | - | -$22.92M(+8.3%) | -$105.96M(+3.4%) |
| Mar 2023 | - | -$21.16M(-51.3%) | -$102.44M(+0.2%) |
| Dec 2022 | -$102.25M(+75.0%) | -$43.45M(+135.9%) | -$102.25M(+30.7%) |
| Sep 2022 | - | -$18.42M(-5.1%) | -$78.23M(+2.3%) |
| Jun 2022 | - | -$19.41M(-7.5%) | -$76.51M(+14.0%) |
| Mar 2022 | - | -$20.98M(+7.9%) | -$67.11M(+14.9%) |
| Dec 2021 | -$58.42M(+28.7%) | -$19.43M(+16.4%) | -$58.42M(+7.3%) |
| Sep 2021 | - | -$16.70M(+66.8%) | -$54.45M(+31.0%) |
| Jun 2021 | - | -$10.01M(-18.5%) | -$41.56M(-6.6%) |
| Mar 2021 | - | -$12.28M(-20.6%) | -$44.50M(-2.0%) |
| Dec 2020 | -$45.39M(-20.1%) | -$15.47M(+307.0%) | -$45.39M(+12.5%) |
| Sep 2020 | - | -$3.80M(-70.6%) | -$40.34M(-22.7%) |
| Jun 2020 | - | -$12.95M(-1.7%) | -$52.18M(+2.9%) |
| Mar 2020 | - | -$13.17M(+26.6%) | -$50.73M(-10.7%) |
| Dec 2019 | -$56.79M(+27.0%) | -$10.41M(-33.5%) | -$56.79M(+22.4%) |
| Sep 2019 | - | -$15.65M(+36.1%) | -$46.38M(-27.4%) |
| Jun 2019 | - | -$11.50M(-40.2%) | -$63.86M(-26.4%) |
| Mar 2019 | - | -$19.24M(-41.9%) | -$86.79M(+8.1%) |
| Dec 2018 | -$44.72M(-15.9%) | - | - |
| Sep 2018 | - | -$33.13M(-3.8%) | -$80.31M(+51.0%) |
| Jun 2018 | -$53.17M(+187.6%) | -$34.43M(+393.4%) | -$53.17M(+113.9%) |
| Mar 2018 | - | -$6.98M(+20.7%) | -$24.86M(+8.0%) |
| Dec 2017 | - | -$5.78M(-3.4%) | -$23.02M(+33.0%) |
| Sep 2017 | - | -$5.98M(-2.2%) | -$17.31M(-6.4%) |
| Jun 2017 | -$18.48M(-14.2%) | -$6.12M(+19.0%) | -$18.48M(-1.4%) |
| Mar 2017 | - | -$5.14M(+7571.6%) | -$18.76M(+0.5%) |
| Dec 2016 | - | -$67.00K(-99.1%) | -$18.66M(-21.5%) |
| Sep 2016 | - | -$7.16M(+12.1%) | -$23.78M(+10.3%) |
| Jun 2016 | -$21.55M(-439.5%) | -$6.39M(+26.7%) | -$21.55M(+6.1%) |
| Mar 2016 | - | -$5.04M(-2.8%) | -$20.31M(+0.2%) |
| Dec 2015 | - | -$5.19M(+5.1%) | -$20.26M(+5.8%) |
| Sep 2015 | - | -$4.93M(-4.1%) | -$19.15M(-401.7%) |
| Jun 2015 | $6.35M(-147.5%) | -$5.15M(+3.0%) | $6.35M(-15.7%) |
| Mar 2015 | - | -$5.00M(+22.7%) | $7.53M(-27.2%) |
| Dec 2014 | - | -$4.08M(-119.8%) | $10.34M(-5.1%) |
| Sep 2014 | - | $20.57M(-618.4%) | $10.90M(-181.6%) |
| Jun 2014 | -$13.36M | -$3.97M(+81.4%) | -$13.36M(+0.1%) |
| Mar 2014 | - | -$2.19M(-37.8%) | -$13.34M(-4.4%) |
| Dec 2013 | - | -$3.51M(-4.7%) | -$13.94M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2013 | - | -$3.69M(-6.6%) | -$13.04M(+9.5%) |
| Jun 2013 | -$11.90M(-52.1%) | -$3.95M(+41.3%) | -$11.90M(+16.5%) |
| Mar 2013 | - | -$2.79M(+7.1%) | -$10.21M(+1.1%) |
| Dec 2012 | - | -$2.61M(+2.2%) | -$10.11M(-59.5%) |
| Sep 2012 | - | -$2.55M(+12.8%) | -$24.96M(+0.5%) |
| Jun 2012 | -$24.84M(+187.8%) | -$2.26M(-15.8%) | -$24.84M(+9.3%) |
| Mar 2012 | - | -$2.69M(-84.6%) | -$22.71M(+0.0%) |
| Dec 2011 | - | -$17.46M(+619.4%) | -$22.71M(+185.8%) |
| Sep 2011 | - | -$2.43M(+1633.6%) | -$7.95M(-7.9%) |
| Jun 2011 | -$8.63M(-198.6%) | -$140.00K(-94.8%) | -$8.63M(-288.2%) |
| Mar 2011 | - | -$2.69M(-0.4%) | $4.58M(+0.4%) |
| Dec 2010 | - | -$2.69M(-13.3%) | $4.57M(-36.9%) |
| Sep 2010 | - | -$3.11M(-123.8%) | $7.24M(-17.3%) |
| Jun 2010 | $8.75M(-448.6%) | $13.07M(-583.3%) | $8.75M(-280.3%) |
| Mar 2010 | - | -$2.71M(>+9900.0%) | -$4.85M(+74.3%) |
| Dec 2009 | - | -$24.00K(-98.5%) | -$2.79M(-23.3%) |
| Sep 2009 | - | -$1.59M(+197.9%) | -$3.63M(+44.6%) |
| Jun 2009 | -$2.51M(-96.7%) | -$534.00K(-16.0%) | -$2.51M(-96.2%) |
| Mar 2009 | - | -$636.00K(-26.9%) | -$65.56M(-6.9%) |
| Dec 2008 | - | -$870.00K(+84.7%) | -$70.42M(-6.5%) |
| Sep 2008 | - | -$471.00K(-99.3%) | -$75.35M(-0.4%) |
| Jun 2008 | -$75.67M(-27.0%) | -$63.58M(+1055.8%) | -$75.67M(+196.4%) |
| Mar 2008 | - | -$5.50M(-5.1%) | -$25.53M(-11.2%) |
| Dec 2007 | - | -$5.79M(+628.9%) | -$28.73M(-14.3%) |
| Sep 2007 | - | -$795.00K(-94.1%) | -$33.55M(-797.5%) |
| Jun 2007 | -$103.67M(+395.7%) | -$13.44M(+54.4%) | $4.81M(-66.1%) |
| Mar 2007 | - | -$8.71M(-17.9%) | $14.21M(-17.8%) |
| Dec 2006 | - | -$10.61M(-128.2%) | $17.29M(-21.9%) |
| Sep 2006 | - | $37.56M(-1029.0%) | $22.13M(-203.3%) |
| Jun 2006 | -$20.91M(+64.0%) | -$4.04M(-28.1%) | -$21.43M(-0.8%) |
| Mar 2006 | - | -$5.62M(-2.5%) | -$21.59M(+14.7%) |
| Dec 2005 | - | -$5.76M(-3.8%) | -$18.81M(+18.1%) |
| Sep 2005 | - | -$5.99M(+42.5%) | -$15.92M(+26.3%) |
| Jun 2005 | -$12.75M(+398.3%) | -$4.21M(+47.7%) | -$12.61M(+42.4%) |
| Mar 2005 | - | -$2.85M(-0.9%) | -$8.85M(+32.0%) |
| Dec 2004 | - | -$2.87M(+7.3%) | -$6.71M(+48.2%) |
| Sep 2004 | - | -$2.68M(+495.0%) | -$4.52M(+83.0%) |
| Jun 2004 | -$2.56M(+37.8%) | -$450.10K(-36.0%) | -$2.47M(-5.9%) |
| Mar 2004 | - | -$703.10K(+1.5%) | -$2.63M(+12.2%) |
| Dec 2003 | - | -$692.80K(+10.6%) | -$2.34M(+15.0%) |
| Sep 2003 | - | -$626.20K(+3.7%) | -$2.04M(+14.1%) |
| Jun 2003 | -$1.86M(-17.5%) | -$603.80K(+44.4%) | -$1.78M(+51.1%) |
| Mar 2003 | - | -$418.00K(+7.8%) | -$1.18M(+54.8%) |
| Dec 2002 | - | -$387.80K(+3.3%) | -$763.20K(+103.3%) |
| Sep 2002 | - | -$375.40K | -$375.40K |
| Jun 2002 | -$2.25M(+418.1%) | - | - |
| Jun 2001 | -$434.60K | - | - |
FAQ
- What is EyePoint Pharmaceuticals annual net profit?
- What is the all time high annual net income for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual net income year-on-year change?
- What is EyePoint Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly net income year-on-year change?
- What is EyePoint Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals TTM net income year-on-year change?
What is EyePoint Pharmaceuticals annual net profit?
The current annual net income of EYPT is -$130.87M
What is the all time high annual net income for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual net profit is $8.75M
What is EyePoint Pharmaceuticals annual net income year-on-year change?
Over the past year, EYPT annual net profit has changed by -$60.08M (-84.86%)
What is EyePoint Pharmaceuticals quarterly net profit?
The current quarterly net income of EYPT is -$45.20M
What is the all time high quarterly net income for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly net profit is $37.56M
What is EyePoint Pharmaceuticals quarterly net income year-on-year change?
Over the past year, EYPT quarterly net profit has changed by -$15.91M (-54.33%)
What is EyePoint Pharmaceuticals TTM net profit?
The current TTM net income of EYPT is -$146.78M
What is the all time high TTM net income for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high TTM net profit is $22.13M
What is EyePoint Pharmaceuticals TTM net income year-on-year change?
Over the past year, EYPT TTM net profit has changed by -$67.87M (-86.00%)